Structure Therapeutics (GPCR) just moved its obesity pipeline up a gear by kicking off a first in human Phase 1 trial for ACCG-2671, its oral amylin receptor agonist targeting metabolic disease. See ...

If you encountered a scenario in which Windows 11 was deactivated after a Disk Clone, this guide is for you. Users clone their hard disk, usually from HDD to SSD, for better performance, but in the ...

Four small satellites rode a Rocket Lab Electron launch vehicle into orbit from Virginia early Thursday, beginning a government-funded technology demonstration mission to test the performance of a new ...

This tool has been developed using both LM Studio and Ollama as LLM providers. The idea behind using a local LLM, like Google's Gemma-3 1B, is data privacy and low cost. In addition, with a good LLM a ...

Abstract: This article introduces a novel approach to data structure visualization through the development of a new programming language, utilizing Python’s Lex-YACC library for lexical analysis and ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...